NCT00834405View on ClinicalTrials.gov

Leflunomide 20 mg Tablets, Non-Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2002

Conditions
Healthy
Interventions
DRUG

ARAVA® 20 mg tablets

1 x 20 mg, single-dose non-fasting

DRUG

Leflunomide 20 mg Tablets

1 x 20 mg, single-dose non-fasting

Trial Locations (2)

63301

Gateway Medical Research, Inc., Saint Charles

77099

Bioassay Laboratory, Inc., Houston

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834405 - Leflunomide 20 mg Tablets, Non-Fasting | Biotech Hunter | Biotech Hunter